On Tuesday, GoodRx Holdings Inc (NASDAQ: GDRX) opened lower -3.93% from the last session, before settling in for the closing price of $4.84. Price fluctuations for GDRX have ranged from $4.09 to $9.26 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 19.48%. Company’s average yearly earnings per share was noted 22.52% at the time writing. With a float of $86.64 million, this company’s outstanding shares have now reached $103.93 million.
Let’s determine the extent of company efficiency that accounts for 694 employees. In terms of profitability, gross margin is 84.0%, operating margin of 5.82%, and the pretax margin is -0.58%.
GoodRx Holdings Inc (GDRX) Insider Activity
A key investor’s attitude towards the stock of the Health Information Services industry is another important factor to consider. The insider ownership of GoodRx Holdings Inc is 77.27%, while institutional ownership is 16.25%. The most recent insider transaction that took place on Dec 02 ’24, was worth 471,451. Before that another transaction happened on Sep 03 ’24, when Company’s 10% Owner sold 10,677 for $7.86, making the entire transaction worth $83,922. This insider now owns 0 shares in total.
GoodRx Holdings Inc (GDRX) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.1 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 22.52% per share during the next fiscal year.
GoodRx Holdings Inc (NASDAQ: GDRX) Trading Performance Indicators
Check out the current performance indicators for GoodRx Holdings Inc (GDRX). In the past quarter, the stock posted a quick ratio of 5.48. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.24. Likewise, its price to free cash flow for the trailing twelve months is 11.54.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.04, a number that is poised to hit 0.09 in the next quarter and is forecasted to reach 0.40 in one year’s time.
Technical Analysis of GoodRx Holdings Inc (GDRX)
Looking closely at GoodRx Holdings Inc (NASDAQ: GDRX), its last 5-days average volume was 1.46 million, which is a jump from its year-to-date volume of 1.13 million. As of the previous 9 days, the stock’s Stochastic %D was 16.62%. Additionally, its Average True Range was 0.22.
During the past 100 days, GoodRx Holdings Inc’s (GDRX) raw stochastic average was set at 17.98%, which indicates a significant increase from 14.89% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 36.70% in the past 14 days, which was lower than the 55.02% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.68, while its 200-day Moving Average is $6.52. However, in the short run, GoodRx Holdings Inc’s stock first resistance to watch stands at $4.87. Second resistance stands at $5.09. The third major resistance level sits at $5.26. If the price goes on to break the first support level at $4.49, it is likely to go to the next support level at $4.32. Should the price break the second support level, the third support level stands at $4.10.
GoodRx Holdings Inc (NASDAQ: GDRX) Key Stats
There are currently 381,142K shares outstanding in the company with a market cap of 1.77 billion. Presently, the company’s annual sales total 750,270 K according to its annual income of -8,870 K. Last quarter, the company’s sales amounted to 195,250 K and its income totaled 3,970 K.
